I think we should be clear that Pfizer did not put $145M into TT-034. That amount was to take TT-034 to commercialisation, which obviously did not occur. No figure on the actual money spent has been released but best guesses on HC have previously been in the $10-12M ballpark. Even so, this is still a reasonable investment which I am sure they would like to recoup if they had the opportunity.
- Forums
- ASX - By Stock
- BLT
- pfizer back in town - tacere last paper
pfizer back in town - tacere last paper, page-23
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online